2.Effect of high mobility group box-1 protein on immune cells and its regulatory mechanism.
Ying-Yi LUAN ; Feng-Hua YAO ; Qing-Hong ZHANG ; Xiao-Mei ZHU ; Ning DONG ; Yong-Ming YAO
Chinese Journal of Applied Physiology 2012;28(6):548-554
High mobility group box-1 protein (HMGB1), which is a nuclear protein, participates in chromatin architecture and transcriptional regulation. When released from cells, HMGB1 also plays a well-established role as a pro-inflammatory mediator during innate immune responses to injury. In the initial stage of injury, there is a release of large quantities of early pro-inflammatory mediators to initiate or perpetuate immune responses against pathogens, but this pro-inflammatory period is transient, and it is followed by a prolonged period of immune suppression. At present, several lines of evidences have suggested that HMGB1 is a late cytokine provoking delayed endotoxin morbidity, which may enhance the production of early proinflammatory mediators, and it can contribute potently to the activation of different immune cells and play a role in the development of host cell-mediated immunity. The biology of HMGB1 has been extensively studied as a pro-inflammatory cytokine of systemic inflammation, however, this review will attempt to provide a summary of the effects of HMGB1 on different immune cells and its regulatory mechanism in acute insults.
Cytokines
;
immunology
;
HMGB1 Protein
;
immunology
;
Humans
;
Immunity, Cellular
;
Inflammation
;
immunology
3.Research progress on immunocyte senescence - review.
Bo YANG ; Xiao-Hua CHI ; Xue-Chun LU ; Shuai TUO ; Feng ZHANG ; Wen-Ying ZHANG ; Chao-Wei TUO ; Wei-Dong HAN ; Shan-Qian YAO
Journal of Experimental Hematology 2012;20(3):782-787
The function of immune system degenerates in an aging-dependent manner and this results in immunosenescence. Human immune system includes two parts: genetic/innate immunity and adaptive immunity. The former is involved in monocytes, nature killer cells, and dendritic cells, the later is involved in acquired B and T lymphocytes. During the aging of immunity system, the both parts of immunity are damaged to some degree. Generally, innate immunity seems well-retained and the acquired immunity is degenerative seriously with aging. Immunocyte senescence is closely related to the elderly decreased ability to control infectious disease, cancer and to their generally poor response to vaccination. This review summarized the research progress on immunosenescence characteristics in aged phase.
Age Factors
;
Aging
;
immunology
;
Antibody Formation
;
immunology
;
Cellular Senescence
;
Humans
;
Immunity, Cellular
;
immunology
;
Lymphocyte Activation
5.The mucosal immune system in the oral cavity-an orchestra of T cell diversity.
Rui-Qing WU ; Dun-Fang ZHANG ; Eric TU ; Qian-Ming CHEN ; WanJun CHEN
International Journal of Oral Science 2014;6(3):125-132
The mucosal immune system defends against a vast array of pathogens, yet it exhibits limited responses to commensal microorganisms under healthy conditions. The oral-pharyngeal cavity, the gateway for both the gastrointestinal and respiratory tracts, is composed of complex anatomical structures and is constantly challenged by antigens from air and food. The mucosal immune system of the oral-pharyngeal cavity must prevent pathogen entry while maintaining immune homeostasis, which is achieved via a range of mechanisms that are similar or different to those utilized by the gastrointestinal immune system. In this review, we summarize the features of the mucosal immune system, focusing on T cell subsets and their functions. We also discuss our current understanding of the oral-pharyngeal mucosal immune system.
Epithelium
;
immunology
;
Humans
;
Immunity, Cellular
;
Immunity, Mucosal
;
immunology
;
Mouth Diseases
;
immunology
;
Mouth Mucosa
;
immunology
;
Pharynx
;
immunology
;
T-Lymphocyte Subsets
;
classification
;
immunology
6.Influence of nutrition on anti-tumor activity.
Seung Hoon CHOI ; Eui Ho HWANG ; Ki Il PARK ; Kyung Sik LEE ; Moritz M ZIEGLER
Yonsei Medical Journal 1991;32(1):44-52
Nutritionally supporting the malnourished tumor bearing host may not benefit the disease outcome, but, rather, may preferentially "feed the cancer". We hypothesized that repletion is beneficial only when it augments an anti-tumor immune response. To support this hypothesis, 240 A/J mice were assigned to isocaloric dietary groups (24%, 5%, or 2.5% protein). On day 14 the mice received either immunogenic C1300- neuroblastoma (NB) or non-immunizing TBJ-NB. On day 21 half of the restricted animals were repleted with 24% protein chow. At day 35, chromium-release cell-mediated cytotoxicity was measured. In the group of mice that received 2.5% protein chow, nutritional repletion specifically augmented anti-tumor activity for C1300-NB which elicits a host immune response (33.78 L.U. (repleted) vs 3.47 L.U. (depleted) p less than 0.01), in contrast, nutritional repletion was detrimental for non-immunizing TBJ-NB, where further depression of cytotoxicity was seen (1.37 L.U. (repleted) vs 2.06 L.U. (depleted) 0 less than 0.01). This suggests that the influence of nutritional repletion in tumor nearing animals is dependent on the integrity of host's anti-tumor immunity.
Animals
;
Body Weight
;
Immunity, Cellular
;
Male
;
Mice
;
Neoplasms, Experimental/*immunology
;
Nutrition Disorders/*immunology
7.Regulation of T cell immunity by cellular metabolism.
Zhilin HU ; Qiang ZOU ; Bing SU
Frontiers of Medicine 2018;12(4):463-472
T cells are an important adaptive immune response arm that mediates cell-mediated immunity. T cell metabolism plays a central role in T cell activation, proliferation, differentiation, and effector function. Specific metabolic programs are tightly controlled to mediate T cell immune responses, and alterations in T cell metabolism may result in many immunological disorders. In this review, we will summarize the main T cell metabolic pathways and the important factors participating in T cell metabolic programming during T cell homeostasis, differentiation, and function.
Animals
;
Cell Physiological Phenomena
;
Humans
;
Immunity, Cellular
;
physiology
;
Metabolic Networks and Pathways
;
immunology
;
T-Lymphocytes
;
immunology
;
metabolism
8.Safety, stability and immunogenicity of an oral DNA vaccine against Newcastle disease.
Xue-Ya LIANG ; Wei-Huan FANG ; Ling-Li JIANG
Chinese Journal of Biotechnology 2003;19(1):24-29
Mice and 3-day-old chickens were orally inoculated with the recombinant attenuated Salmonella typhimurium strain ZJ111 carrying pcDNA3-F expression plasmid encoding the fusion protein of Newcastle disease virus (NDV). The results showed that ZJ111/pcDNA3-F was relatively safe. The recombinant plasmid pcDNA3-F was stable within the host stain ZJ111 in vitro and in vivo as shown by restriction enzyme analysis and PCR identification of the F gene. In an experimental vaccination study, 3-day-old chickens were orally immunized with ZJ111/pcDNA3-F with a dose of 108 cfu per chicken and boosted two weeks later. At week 4 post boosting, all chickens were challenged with a lethal dose of a virulent NDV strain F48 E9. The results showed that oral vaccination with ZJ111/pcDNA3-F induced stronger humoral and cellular immune responses than intramuscular immunization with naked pcDNA3-F plasmid. It also exhibited higher protection rate than the latter (66.7% vs 50%). This study indicates that the DNA vaccine using attenuated Salmonella typhimurium as delivery carrier had good safety, stability and immunogenicity and exhibited good potential of low cost and convenience for poultry disease control.
Animals
;
Chickens
;
Immunity, Cellular
;
immunology
;
Immunity, Humoral
;
immunology
;
Mice
;
Newcastle Disease
;
immunology
;
virology
;
Plasmids
;
Polymerase Chain Reaction
;
Salmonella typhimurium
;
genetics
;
metabolism
;
Vaccines, DNA
;
adverse effects
;
genetics
;
immunology
9.Cellular and humoral immunity in preterm infants of different gestational ages.
Yan LI ; Qiu-Fen WEI ; Xin-Nian PAN ; Dan-Hua MENG ; Xian-Zhi LIU ; Jing XU ; Wei WEI
Chinese Journal of Contemporary Pediatrics 2014;16(11):1118-1121
OBJECTIVETo investigate the characteristics of immune function in newborn infants of different gestational ages.
METHODSA total of 115 premature infants free of infection between June 1, 2012 and June 1, 2013 were divided into two groups according to their gestational age at birth: early preterm infant group (28-33+6 weeks, n=57) and late preterm infant group (34-36+6 weeks, n=58). Meanwhile, 88 full-term infants (37-41+6 week) were recruited to the control group. Venous blood samples were collected within 24 hours after birth. The percentages of lymphocyte subsets, such as CD3+, CD4+, CD8+, and CD19+ T cells and natural killer (NK) cells were measured by flow cytometry, and the absolute count of each population was calculated using the results from routine blood work. Concentrations of serum IgG, IgA, and IgM were measured by immunoturbidimetry.
RESULTSBoth preterm infant groups had significantly higher percentages of CD3+ and CD4+ T cells and CD4+/CD8+ ratio (P<0.05) and significantly lower percentages of CD8+ and CD19+ T cells and NK cells (P<0.05), as compared with the full-term infant group. The absolute counts of total lymphocytes, CD3+, CD4+, CD8+, and CD19+ T cells, and NK cells in both preterm infant groups were significantly lower than those in the full-term infant group (P<0.05), and the above parameters in the late preterm infant group were significantly higher than those in the early preterm infant group (P<0.05). Both preterm infant groups showed significantly lower concentrations of serum IgG than the full-term infant group (P<0.05), while no significant differences in concentrations of serum IgA and IgM were observed between the three groups (P>0.05).
CONCLUSIONSNeonatal gestational age has an effect on cellular and humoral immunity. The immune function gradually improves with increasing gestational age.
CD4-CD8 Ratio ; Gestational Age ; Humans ; Immunity, Cellular ; Immunity, Humoral ; Immunoglobulins ; blood ; Infant, Newborn ; Infant, Premature ; immunology ; Lymphocyte Count
10.Cellular immunity induced by CD40 ligand-activated dendritic cells in CEA transgenic mice.
Jian-wei HU ; Xin-qiang HONG ; Xin-yu QIN ; Li-qing YAO ; Jian-min XU ; Wei-xin NIU
Chinese Journal of Gastrointestinal Surgery 2009;12(5):518-521
OBJECTIVETo investigate the role of CD40 ligand (CD40L) in dendritic cells (DC) of CEA transgenic mice and to evaluate the specific cellular immunity induced by activated DC.
METHODSBone marrow cells of the CEA transgenic mice were used to generate immature dendritic cells under the condition of GM-CSF and IL-4. CD40L was added to activate dendritic cells into mature phenotype. Dendritic cells cancer vaccine was pulsed with CEA526-533 peptide which made the vaccine specific for cancer immunity. The immunophenotype molecules were identified by flow cytometry. The cytokines produced by cells were determined by ELISA. T cells proliferation was measured by (3)H-thymidine essays.
RESULTSImmunophenotype molecules expressions of CD40L-activated dendritic cells were significantly higher than those in control group. IL-12 secretion by CD40L-activated dendritic cells was (937.81+/-51.99) pg/10(6) DC, significantly higher than that in control group [(83.06+/-8.58) pg/10(6) DC, P<0.01]. CD8(+) T cells proliferation induced by CD40 L-activated dendritic cells was stronger as compared to control group (P<0.05), and the secretion of IFN-gamma was(33.900+/-4.550) ng/L, significantly higher than that in control group [(5.226+/-0.460) ng/L, P<0.01]. Splenocytes proliferation induced by CD40 L-activated dendritic cells was stronger as compared to control group (P<0.01), and the secretion of IFN-gamma was (69.802+/-11.407) ng/L, significantly higher than that in control group [(2.912+/-0.562) ng/L, P<0.01].
CONCLUSIONThe method of using CD40L to stimulate bone marrow-delivered dendritic cells promotes the maturation and activation of dendritic cells, which enhances the cellular immunity in CEA transgenic mice.
Animals ; CD40 Ligand ; immunology ; physiology ; Dendritic Cells ; cytology ; immunology ; metabolism ; Immunity, Cellular ; immunology ; Mice ; Mice, Inbred C57BL ; Mice, Transgenic